Owned by the Association for International Promotion & Study in Tumors (APSIT)
Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR
The transmembrane receptor Kremen2 has been reported to participate in the tumorigenesis and metastasis of gastric cancer. However, the role of Kremen2 in non-small cell lung cancer (NSCLC) and the underlying ...